Study of the Duration, Outcomes, and Related Factors of Reperfusion Therapy in Patients with ST-Segment Elevation Myocardial Infarction
Authors
Abstract:
Background and Objective: One of the most important advancements regarding the care of patients with acute myocardial infarction is the administration of anti-coagulation medicines (e.g., streptokinase). However, it must be noticed that this medicine requires rapid and timely administration. Moreover, Percutaneous Coronary Intervention (PCI) is increasingly used as a method of revascularization. Considering the importance of time for the effective use of these methods, the present study aimed to investigate the duration of the process, treatment outcome, and its associated factors in patients with ST-segment elevation myocardial infarction (STEMI) who were candidates for streptokinase or PCI. Materials and Methods: The present descriptive-analytical study made use of total population sampling so that all patients with STEMI who did not meet the exclusion criteria were included in the study in 2017. The study population consisted of 183 patients who had referred to the emergency ward of Tohid Hospital in Sanandaj, Iran. The patients were investigated regarding their age, gender, day of admission, pain-to-admission time, the average travel time to the hospital, type of referral, underlying illness, time of myocardial infarction diagnosis, starting time of reperfusion therapy, and final outcome. The collected data were recorded in the designed forms and then entered into SPSS software (version 22). Descriptive statistics formulas (i.e., mean, standard deviation, and percentage) were used regarding research questions. Moreover, regarding the research hypotheses, the chi-square test and correlation coefficients were used in the case of qualitative and quantitative variables, respectively. Results: According to the results, the majority of patients were male patients over 50 years old with no history of myocardial infarction. A total of 146 (79.8%) and 37 (20.2%) of participants were male and female, respectively. Moreover, the mean age of the participants was 58.52 and 28 of them (15.3%) had a history of myocardial infarction. The mean duration time of ECG and myocardial infarction diagnosis was 4.2 and 18.85 min, respectively. Furthermore, the mean duration time from patient admission to receiving intervention was estimated at 107.68 min. It should also be mentioned that their average length of hospital stay was 4.9 days. Conclusion: Based on the results, it can be said that the mortality rate was higher in older patients than in others. Moreover, the duration of ECG in female patients was longer in comparison to the male patients. In addition, starting the reperfusion therapy took longer in the night shifts.
similar resources
Reperfusion Therapy for ST-Segment Elevation Myocardial Infarction
Reperfusion therapy represents an important step forward in the management of patients with ST-segment elevation myocardial infarction (STEMI). Few medicinal treatments have been evaluated so well. In numerous randomized controlled trials, reperfusion therapy proved to reduce infarct size and improve early and long-term clinical outcome when compared with control treatment. The cornerstones of ...
full textPrevalence of Cardiovascular Risk Factors, Reperfusion Therapy and Mortality in Patients With ST-Elevation Myocardial Infarction in Elderly and Middle-ages
Objectives The prevalence of cardiovascular risk factors is different in the elderly and middle-aged. Therefore the present study aims to compare the prevalence of risk factors affecting ST-elevation myocardial infarction (STEMI), type of treatment, and mortality rate in these two groups. Methods & Materials This retrospective cohort study included 1 071 elderly and middle-aged ST-elevation my...
full textThe streptokinase therapy complications and its associated risk factors in patients with acute ST elevation myocardial infarction
Acute myocardial infarction (AMI) is one of the main leading causes of mortality and morbidity. Despite the progress in the treatment of AMI, streptokinase is still being used in many countries. Because of the critical condition of patients with AMI and complications of streptokinase therapy, this study was performed to evaluate the pattern of adverse drug reaction (ADRs) induced by streptokina...
full textThe streptokinase therapy complications and its associated risk factors in patients with acute ST elevation myocardial infarction
Acute myocardial infarction (AMI) is one of the main leading causes of mortality and morbidity. Despite the progress in the treatment of AMI, streptokinase is still being used in many countries. Because of the critical condition of patients with AMI and complications of streptokinase therapy, this study was performed to evaluate the pattern of adverse drug reaction (ADRs) induced by streptokina...
full texteffect of streptokinase on short-term outcomes in the acute myocardial infarction with st-segment elevation
acute coronary syndrome is one of the most prevalent cardiovascular diseases. the acute myocardial infarction is one of its kinds which embodies the indication of fibrinolysis. one of the fibrinolytic types mostly used in iran is streptokinase (sk). this study aims to study the short-term clinical outcomes after receiving sk.a prospective cohort study was conducted on 54 patients at hospitals a...
full textReperfusion times of ST-Segment elevation myocardial infarction in hospitals
OBJECTIVE To investigate the reperfusion time in patients with ST-segment elevation myocardial infarction (STEMI) in Henan Province, China, and discuss the strategies for shortening that period. METHODS The reperfusion times of 1556 STEMI cases in 30 hospitals in Henan Province were analyzed from January 2008 to August 2012, including 736 cases from provincial hospitals, 462 cases from munici...
full textMy Resources
Journal title
volume 26 issue 4
pages 220- 226
publication date 2020-03
By following a journal you will be notified via email when a new issue of this journal is published.
No Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023